자기공명영상(MRI) 기기 시장 규모는 2024년 82억 706만 달러에서 예측 기간 동안 연평균 6.54%(CAGR) 성장하여 2032년에는 135억 5,333만 달러 규모로 성장할 것으로 예상됩니다.
심혈관질환, 암, 신경질환 등 다양한 만성질환의 유병률이 증가함에 따라 연부조직과 장기의 우수한 영상화 능력을 제공하는 MRI와 같은 정밀 진단 도구에 대한 수요가 증가하고 있습니다. 또한, 만성질환의 조기 진단에 대한 인식이 높아지면서 환자와 의료진이 적시에 개입할 수 있도록 MRI를 활용하도록 유도하고 있습니다. 또한, 고자기장 및 개방형 MRI 시스템, 기능적 MRI(fMRI) 스캔 시간 단축과 같은 기술 혁신은 영상화 과정의 정확성, 편안함, 효율성을 향상시키고 있습니다. 이러한 요인으로 인해 예측 기간 동안 이 장비에 대한 수요는 전 세계적으로 확대될 것으로 예상됩니다.
시장 역학:
GLOBOCAN의 최신 데이터(2024년)에 따르면, 2022년 전 세계에서 새로 발생한 암 환자는 약 2,000만 명으로 추산되며, 2045년에는 3,260만 명으로 늘어날 것으로 예상됩니다. 연부조직의 이미지를 제공하여 종양 영역에서 매우 중요한 역할을 하고 있습니다. 전 세계적으로 암 부담이 증가함에 따라 환자에게 전리방사선을 조사하지 않고도 종양의 위치를 정확하게 파악하고 크기를 평가하고 병기를 결정할 수 있는 첨단 영상기술에 대한 수요가 급증하고 있으며, 이는 세계 시장 성장을 주도하고 있습니다.
신경암에 초점을 맞추면, GLOBOCAN(2022) 데이터에 따르면 뇌 및 중추신경계(CNS) 암의 전 세계 발생률은 약 32만 2,000건이며, 2045년까지 47만 4,000건으로 증가할 것으로 예상됩니다. 동시에 British Heart Foundation(2024년)의 추산에 따르면 전 세계 뇌졸중 생존자는 약 1억 명, 그 중 여성은 5,600만 명, 남성은 4,500만 명에 달하며, MRI는 비침습적이고 뇌조직의 정상과 이상을 식별할 수 있기 때문에 뇌종양, 중추신경계 암, 기타 신경질환의 진단에 필수적인 도구입니다. 뇌졸중 진단에서 특수 MRI 기술인 확산강조영상(DWI)은 허혈성 뇌졸중을 조기에 발견하고, 뇌조직 손상을 평가하고, 적시에 개입할 수 있도록 안내하는 데 필수적이며, MRI를 통한 조기 발견은 신속한 치료 결정을 용이하게 할 뿐만 아니라 장기적인 합병증을 최소화하기 때문에 이러한 장비에 대한 수요를 더욱 증가시키고 있습니다.
기술 발전과 신제품 출시도 MRI 시장을 지속적으로 강화하고 있습니다. 예를 들어, Hitachi Medical Systems는 2021년 3월 유럽방사선학회(European Congress of Radiology)에서 두 개의 상설 개방형 MRI 시스템을 발표했습니다. 두 시스템은 SynergyDrive 워크플로우 솔루션과 통합되어 촬영 속도, 효율성 및 환자 편의성을 향상시킵니다. 이러한 혁신은 의료기관의 운영 워크플로우를 개선하는 동시에 주요 임상적 요구사항을 충족하는 데 도움이 될 것으로 기대됩니다.
이러한 발전에도 불구하고, 몇 가지 도전과제가 시장 성장을 저해할 수 있습니다. 안전 문제나 기술적 결함으로 인한 제품 리콜이 증가하면 사용자들의 신뢰를 떨어뜨리고 기기 보급을 지연시킬 수 있습니다. 또한, 환자 안전에 필수적이지만 기기 승인을 위한 엄격한 규제 요건으로 인해 혁신적인 제품의 시장 출시가 지연될 수 있습니다.
세계의 자기공명영상(MRI) 기기 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법·규제 환경, 시장 규모 추정과 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
Magnetic Resonance Imaging (MRI) Devices Market by Field Strength (High-Field MRI Systems (1.5t to 3t), Low-to-Mid-Field MRI Systems (<1.5t), and Very-High-Field MRI Systems (4t And Above), Architecture (Closed MRI Systems, Wide-Bore MRI, and Open MRI Systems), Application (Musculoskeletal, Gastroenterology, Neurology, Oncology, and Others), End-User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising prevalence of various chronic disorders, increasing awareness and early diagnosis, growing technological advancements, and increase in product development activities by key market players across the globe.
The magnetic resonance imaging devices market was valued at USD 8,207.06 million in 2024, growing at a CAGR of 6.54% during the forecast period from 2025 to 2032 to reach USD 13,553.33 million by 2032. The rising prevalence of various chronic disorders, such as cardiovascular diseases, cancer, and neurological conditions, is fueling the demand for precise diagnostic tools like MRI, which offers superior imaging capabilities for soft tissues and organs. Additionally, the increasing awareness and the emphasis on early diagnosis of chronic disease are encouraging patients and healthcare providers to adopt MRI for timely intervention. Furthermore, technological advancements play a crucial role in boosting the MRI market, with innovations such as high-field and open MRI systems, functional MRI (fMRI), and faster scan times improving the accuracy, comfort, and efficiency of the imaging process. Collectively, these factors are expected to expand the demand for magnetic resonance imaging devices globally during the forecast period from 2025 to 2032.
Magnetic Resonance Imaging Devices Market Dynamics:
According to recent data from GLOBOCAN (2024), there were an estimated 20 million new cancer cases worldwide in 2022, with projections indicating a rise to 32.6 million by 2045. Magnetic resonance imaging (MRI) devices play a pivotal role in oncology, offering highly detailed soft tissue images that are crucial for detecting tumors in organs such as the brain, breast, liver, prostate, and pancreas. As the global cancer burden intensifies, there is a surging demand for advanced imaging technologies capable of precisely locating tumors, evaluating their size, and determining disease stage all without exposing patients to ionizing radiation thereby driving the global market growth.
Focusing on neurological cancers, GLOBOCAN (2022) data reveals that the global incidence of brain and central nervous system (CNS) cancers was approximately 322,000 cases, with projections set to increase to 474,000 by 2045. Concurrently, the British Heart Foundation (2024) estimates that there are about 100 million stroke survivors worldwide, including 56 million women and 45 million men. MRI's non-invasive nature and ability to distinguish between normal and abnormal brain tissues make it an essential tool for diagnosing brain tumors, CNS cancers, and other neurological conditions. In stroke diagnosis, diffusion-weighted imaging (DWI) a specialized MRI technique is vital for early identification of ischemic strokes, assessing brain tissue damage, and guiding timely interventions. Early detection through MRI not only facilitates rapid treatment decisions but also minimizes long-term complications, further propelling demand for these devices.
Technological advancements and new product launches continue to strengthen the MRI market. For instance, in March 2021, Hitachi Medical Systems launched two permanent open MRI systems at the European Congress of Radiology, both integrated with the SynergyDrive workflow solution to enhance imaging speed, efficiency, and patient comfort. Such innovations address key clinical needs while improving operational workflows in healthcare facilities.
Despite these advancements, certain challenges could impede market growth. A rising number of product recalls often due to safety concerns or technical malfunctions can undermine user confidence and delay device adoption. Additionally, stringent regulatory requirements for device approval, though essential for patient safety, may slow down the introduction of innovative products to the market.
In conclusion, while increasing cancer incidence, technological innovations, and rising neurological and cardiovascular disease prevalence continue to drive the global MRI devices market, overcoming regulatory hurdles and addressing product reliability issues will be crucial to sustaining long-term growth.
Magnetic Resonance Imaging Devices Market Segment Analysis:
Magnetic Resonance Imaging (MRI) Devices Market by Field Strength (High-Field MRI Systems (1.5t to 3t), Low-to-Mid-Field MRI Systems (<1.5t), and Very-High-Field MRI Systems (4t And Above), Architecture (Closed MRI Systems, Wide-Bore MRI, and Open MRI Systems), Application (Musculoskeletal, Gastroenterology, Neurology, Oncology, and Others), End-User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the field strength segment of the global magnetic resonance imaging (MRI) devices market, high-field MRI systems (1.5T to 3T) are projected to hold the largest market share in 2024. These systems are driving overall market growth due to their superior imaging capabilities, making them the preferred choice for a wide range of clinical applications. High-field MRIs offer higher spatial resolution, faster scan times, and enhanced diagnostic accuracy compared to lower-field MRI machines, enabling detailed visualization of fine anatomical structures. This makes them particularly valuable for brain, spine, and cardiovascular imaging, where precise anatomical details are crucial for accurate diagnosis and treatment planning.
One of the significant advantages of high-field MRI systems is their ability to support advanced functional imaging techniques such as functional MRI (fMRI) and diffusion tensor imaging (DTI), both essential for neurological assessments and pre-surgical planning. In oncology, high-field MRIs play a vital role in detecting and monitoring tumors, especially in anatomically challenging areas like the prostate, liver, and pancreas, where early detection significantly impacts patient outcomes. Moreover, the rising prevalence of chronic diseases, increasing demand for early diagnosis, and the growing number of MRI installations in hospitals, diagnostic centers, and research institutions are further fueling the adoption of these systems.
Technological advancements have also contributed to the market expansion of high-field MRI systems. Innovations such as faster acquisition sequences, motion correction technologies, and AI-powered image reconstruction are improving image quality while reducing scan times and patient discomfort. Additionally, the development of open high-field MRI systems addresses the common issue of patient claustrophobia and expands the usability of MRI for pediatric, elderly, and bariatric patients.
For instance, on November 29, 2021, FUJIFILM Healthcare Americas Corporation launched its advanced high-field open MRI system the Velocity MRI System during the 2021 Radiological Society of North America (RSNA) conference. This system is designed to streamline workflow and enhance patient comfort with its unique open gantry, integrated radiofrequency (RF) coils, and advanced reconstruction technologies. Notably, the Synergy Flex coil, the first of its kind in an open, vertical-field MRI scanner, promotes fast and efficient abdominal and orthopedic imaging. Such innovations are pivotal in expanding MRI accessibility while maintaining high diagnostic performance.
Despite these advancements, challenges such as high equipment costs, installation complexities, and strict regulatory requirements for product approvals may pose hurdles to market growth. However, the increasing demand for non-invasive diagnostic imaging, coupled with technological innovations aimed at improving patient comfort and operational efficiency, is expected to generate substantial revenue and propel the growth of the global high-field MRI devices segment throughout the forecast period.
North America is expected to dominate the overall magnetic resonance imaging devices market:
Among all regions, North America is projected to hold the largest share in the global magnetic resonance imaging (MRI) devices market in 2024. This dominance can be attributed to several factors, including the rising prevalence of neurological disorders, cardiovascular diseases, and cancer, coupled with technological advancements, favorable government initiatives, and the strong presence of key market players engaged in strategic activities across the region.
The growing burden of neurological disorders is a significant driver. According to the Alzheimer's Association (2024), approximately 6.9 million Americans aged 65 and older are living with Alzheimer's disease. Similarly, data from the Parkinson's Foundation (2022) indicates that nearly 90,000 people are diagnosed with Parkinson's disease annually in the U.S., with approximately one million Americans living with the condition a figure expected to rise to 1.2 million by 2030. MRI's capability to deliver high-resolution images and advanced functional imaging techniques, such as functional MRI (fMRI) and magnetic resonance spectroscopy (MRS), plays a crucial role in detecting early structural and functional brain changes, thereby aiding in the diagnosis and management of these neurodegenerative diseases.
Cancer prevalence further accelerates the demand for MRI systems in North America. As per GLOBOCAN (2024), the region reported an estimated 2.67 million new cancer cases in 2022, with projections reaching 3.83 million by 2045. For cancers located in complex anatomical areas such as the brain, spinal cord, and pelvis MRI offers superior imaging compared to other modalities, enhancing tumor detection, treatment planning, and monitoring. This increased demand for precise, non-invasive imaging solutions is a key factor propelling the market.
Technological innovation and regulatory approvals also play a pivotal role in market expansion. In January 2024, Siemens Healthineers received FDA clearance for its MAGNETOM Cima.X 3 Tesla (3T) whole-body MRI scanner. This next-generation system features the strongest gradient system ever released for clinical use in whole-body imaging, allowing for faster scan times and enhanced visualization of small anatomical structures. The MAGNETOM Cima.X is designed to address critical imaging challenges, especially in cancer diagnostics, and supports advanced research with features tailored for complex imaging requirements.
Furthermore, the active involvement of key market players in launching new products, forming strategic partnerships, and expanding their regional presence continues to bolster market growth. Government initiatives aimed at improving diagnostic infrastructure and enhancing access to advanced medical technologies further strengthen the region's market position.
In conclusion, the interplay of rising disease prevalence, technological advancements, regulatory support, and strategic industry initiatives is expected to significantly boost the adoption of MRI devices in North America, driving substantial market growth throughout the forecast period.
Magnetic Resonance Imaging Devices Market Key Players:
Some of the key market players operating in the magnetic resonance Imaging devices market include General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, ESAOTE SPA, Aspect Imaging Ltd., Bruker Corporation, Aurora Healthcare US Corp., FONAR Corp., Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., Time Medical Holding, Hyperfine, Alltech Medical Systems, InnerVision MRI Ltd., Magnetica Limited, IMRIS, Deerfield Imaging, Inc., and others.
Recent Developmental Activities in the Magnetic Resonance Imaging Devices Market:
Key Takeaways from the Magnetic Resonance Imaging Devices Market Report Study:
Target Audience Who Can be Benefited from this Magnetic Resonance Imaging Devices Market Report Study:
Frequently Asked Questions for the Magnetic Resonance Imaging Devices Market: